Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Association between ApoE phenotypes and telomere erosion in Alzheimer's disease.

Takata Y, Kikukawa M, Hanyu H, Koyama S, Shimizu S, Umahara T, Sakurai H, Iwamoto T, Ohyashiki K, Ohyashiki JH.

J Gerontol A Biol Sci Med Sci. 2012 Apr;67(4):330-5. doi: 10.1093/gerona/glr185. Epub 2011 Oct 19.

PMID:
22016362
2.

Cognitive impairment in Alzheimer's disease is modified by APOE genotype.

van der Vlies AE, Pijnenburg YA, Koene T, Klein M, Kok A, Scheltens P, van der Flier WM.

Dement Geriatr Cogn Disord. 2007;24(2):98-103. Epub 2007 Jun 26.

PMID:
17596691
3.

Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.

Craft S, Teri L, Edland SD, Kukull WA, Schellenberg G, McCormick WC, Bowen JD, Larson EB.

Neurology. 1998 Jul;51(1):149-53.

PMID:
9674794
4.

Relative telomere length in patients with late-onset Alzheimer's dementia or vascular dementia.

Löf-Ohlin ZM, Hagnelius NO, Nilsson TK.

Neuroreport. 2008 Aug 6;19(12):1199-202. doi: 10.1097/WNR.0b013e3283089220.

PMID:
18628664
5.

ApoE genotyping and response to galanthamine in Alzheimer's disease--a real life retrospective study.

Babić T, Mahović Lakusić D, Sertić J, Petrovecki M, Stavljenić-Rukavina A.

Coll Antropol. 2004 Jun;28(1):199-204.

PMID:
15636076
7.

APOE epsilon 3/ epsilon 4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis.

Fukumoto H, Ingelsson M, Gårevik N, Wahlund LO, Nukina N, Yaguchi Y, Shibata M, Hyman BT, Rebeck GW, Irizarry MC.

Exp Neurol. 2003 Sep;183(1):249-53.

PMID:
12957508
8.

Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases.

Lamb H, Christie J, Singleton AB, Leake A, Perry RH, Ince PG, McKeith IG, Melton LM, Edwardson JA, Morris CM.

Neurology. 1998 Feb;50(2):388-91.

PMID:
9484359
9.
10.
11.

Association between apolipoprotein E polymorphism and Alzheimer's disease in Koreans.

Kim KW, Jhoo JH, Lee KU, Lee DY, Lee JH, Youn JY, Lee BJ, Han SH, Woo JI.

Neurosci Lett. 1999 Dec 31;277(3):145-8.

PMID:
10626834
12.

Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.

Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT.

Ann Neurol. 1996 Jan;39(1):62-70.

PMID:
8572669
13.

Apolipoprotein E genotypes in sporadic early and late-onset Alzheimer's disease.

Kowalska A, Florczak J, Pruchnik-Wolińska D, Kraszewski A, Wender M.

Arch Immunol Ther Exp (Warsz). 1998;46(3):177-81.

PMID:
9704150
14.

Association of a polymorphism of the transforming growth factor-beta1 gene with cerebral amyloid angiopathy.

Hamaguchi T, Okino S, Sodeyama N, Itoh Y, Takahashi A, Otomo E, Matsushita M, Mizusawa H, Yamada M.

J Neurol Neurosurg Psychiatry. 2005 May;76(5):696-9.

15.

Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer's disease.

Norrman J, Brookes AJ, Yates C, St Clair D.

Br J Psychiatry. 1995 Oct;167(4):533-6.

PMID:
8829725
16.

Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease.

Thomas P, O' Callaghan NJ, Fenech M.

Mech Ageing Dev. 2008 Apr;129(4):183-90. doi: 10.1016/j.mad.2007.12.004. Epub 2008 Feb 1.

PMID:
18242664
17.

Rapid detection of apolipoprotein E genotypes in Alzheimer's disease using polymerase chain reaction-single strand conformation polymorphism.

Kamruecha W, Chansirikarnjana S, Nimkulrat E, Udommongkol C, Wongmek W, Thangnipon W.

Southeast Asian J Trop Med Public Health. 2006 Jul;37(4):793-7.

PMID:
17121308
18.

Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study.

Ganguli M, Chandra V, Kamboh MI, Johnston JM, Dodge HH, Thelma BK, Juyal RC, Pandav R, Belle SH, DeKosky ST.

Arch Neurol. 2000 Jun;57(6):824-30.

PMID:
10867779
19.

Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.

Dal Forno G, Rasmusson DX, Brandt J, Carson KA, Brookmeyer R, Troncoso J, Kawas CH.

Arch Neurol. 1996 Apr;53(4):345-50.

PMID:
8929157
20.

The impact of apolipoprotein E4 on cause of death in Alzheimer's disease.

Olichney JM, Sabbagh MN, Hofstetter CR, Galasko D, Grundman M, Katzman R, Thal LJ.

Neurology. 1997 Jul;49(1):76-81.

PMID:
9222173

Supplemental Content

Support Center